ID

44494

Beschrijving

A Phase I/II Study of HE3235 in Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00716794

Link

https://clinicaltrials.gov/show/NCT00716794

Trefwoorden

Versies (2)
  1. 08-09-18 08-09-18 -
  2. 27-09-21 27-09-21 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

27 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Prostate Cancer NCT00716794

Engels

Eligibility Prostate Cancer NCT00716794

1 Formulieren  
Criteria
Beschrijving

Criteria

patient is male and at least 18 years of age, at the time of screening;
Beschrijving

Gender | Age

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
patient has metastatic disease (any t, any n, m1);
Beschrijving

Neoplasm Metastasis TNM clinical staging

Datatype

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C3258246
patient has failed at least 1 taxane regimen; or patient has symptomatic or asymptomatic crpc and is chemotherapy-naïve
Beschrijving

Taxane Regimen Quantity failed | CRPC Symptomatic | CRPC Asymptomatic | Chemotherapy naive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0215136
UMLS CUI [1,2]
C0040808
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0231175
UMLS CUI [2,1]
C1328504
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C1328504
UMLS CUI [3,2]
C0231221
UMLS CUI [4,1]
C0392920
UMLS CUI [4,2]
C0919936
patient has histologically or cytologically confirmed adenocarcinoma of the prostate;
Beschrijving

Adenocarcinoma of prostate

Datatype

boolean

Alias
UMLS CUI [1]
C0007112
patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:
Beschrijving

Disease Progression | Hormone Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0279025
psa level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.
Beschrijving

Prostate specific antigen measurement | Raised prostate specific antigen Quantity

Datatype

boolean

Alias
UMLS CUI [1]
C0201544
UMLS CUI [2,1]
C0178415
UMLS CUI [2,2]
C1265611
evaluable disease progression by modified recist (response evaluation criteria in solid tumors) criteria;
Beschrijving

Evaluable Disease Progression

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516986
UMLS CUI [1,2]
C0242656
progression of metastatic bone disease on bone scan with > 2 new lesions
Beschrijving

Secondary malignant neoplasm of bone Progression Bone scan | Lesion New Quantity Bone scan

Datatype

boolean

Alias
UMLS CUI [1,1]
C0153690
UMLS CUI [1,2]
C0449258
UMLS CUI [1,3]
C0203668
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C0205314
UMLS CUI [2,3]
C1265611
UMLS CUI [2,4]
C0203668
patient has ecog (eastern cooperative oncology group) performance status of 0-2;
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
main exclusion criteria:
Beschrijving

Exclusion Criteria Main

Datatype

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation treated epidural disease is allowed
Beschrijving

Metastatic malignant neoplasm to brain Parenchymal Symptomatic | Epidural space Disease Requirement Whole brain radiation therapy | Epidural space Disease Treated allowed

Datatype

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C4277702
UMLS CUI [1,3]
C0231220
UMLS CUI [2,1]
C0228134
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C1514873
UMLS CUI [2,4]
C1520143
UMLS CUI [3,1]
C0228134
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C1522326
UMLS CUI [3,4]
C0683607
patient has active infection;
Beschrijving

Communicable Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0009450
patient having a history of clinically significant cardiovascular disease (such as chf), clinically significant hepatic, respiratory or renal abnormalities;
Beschrijving

Cardiovascular Disease | Congestive heart failure | Liver Dysfunction | Respiratory abnormality | Abnormal renal function

Datatype

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0018802
UMLS CUI [3]
C0086565
UMLS CUI [4]
C4018871
UMLS CUI [5]
C0151746
patient who has any clinically significant abnormalities in laboratory results at screening
Beschrijving

Laboratory test result abnormal

Datatype

boolean

Alias
UMLS CUI [1]
C0438215
patient who has a history of clinically significant neurological or psychiatric condition;
Beschrijving

Nervous system disorder | Mental condition Clinical Significance

Datatype

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C2826293
additional criteria are applicable to expansion cohorts.
Beschrijving

Criteria Additional | Cohort Expanded

Datatype

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1524062
UMLS CUI [2,1]
C0599755
UMLS CUI [2,2]
C0205229
Terug naar het begin van de pagina

Similar models

Eligibility Prostate Cancer NCT00716794

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Gender | Age
Item
patient is male and at least 18 years of age, at the time of screening;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Neoplasm Metastasis TNM clinical staging
Item
patient has metastatic disease (any t, any n, m1);
boolean
C0027627 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Taxane Regimen Quantity failed | CRPC Symptomatic | CRPC Asymptomatic | Chemotherapy naive
Item
patient has failed at least 1 taxane regimen; or patient has symptomatic or asymptomatic crpc and is chemotherapy-naïve
boolean
C0215136 (UMLS CUI [1,1])
C0040808 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C1328504 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C1328504 (UMLS CUI [3,1])
C0231221 (UMLS CUI [3,2])
C0392920 (UMLS CUI [4,1])
C0919936 (UMLS CUI [4,2])
Adenocarcinoma of prostate
Item
patient has histologically or cytologically confirmed adenocarcinoma of the prostate;
boolean
C0007112 (UMLS CUI [1])
Disease Progression | Hormone Therapy
Item
patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:
boolean
C0242656 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
Prostate specific antigen measurement | Raised prostate specific antigen Quantity
Item
psa level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.
boolean
C0201544 (UMLS CUI [1])
C0178415 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Evaluable Disease Progression
Item
evaluable disease progression by modified recist (response evaluation criteria in solid tumors) criteria;
boolean
C1516986 (UMLS CUI [1,1])
C0242656 (UMLS CUI [1,2])
Secondary malignant neoplasm of bone Progression Bone scan | Lesion New Quantity Bone scan
Item
progression of metastatic bone disease on bone scan with > 2 new lesions
boolean
C0153690 (UMLS CUI [1,1])
C0449258 (UMLS CUI [1,2])
C0203668 (UMLS CUI [1,3])
C0221198 (UMLS CUI [2,1])
C0205314 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0203668 (UMLS CUI [2,4])
ECOG performance status
Item
patient has ecog (eastern cooperative oncology group) performance status of 0-2;
boolean
C1520224 (UMLS CUI [1])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Parenchymal Symptomatic | Epidural space Disease Requirement Whole brain radiation therapy | Epidural space Disease Treated allowed
Item
patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation treated epidural disease is allowed
boolean
C0220650 (UMLS CUI [1,1])
C4277702 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
C0228134 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C1514873 (UMLS CUI [2,3])
C1520143 (UMLS CUI [2,4])
C0228134 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C0683607 (UMLS CUI [3,4])
Communicable Disease
Item
patient has active infection;
boolean
C0009450 (UMLS CUI [1])
Cardiovascular Disease | Congestive heart failure | Liver Dysfunction | Respiratory abnormality | Abnormal renal function
Item
patient having a history of clinically significant cardiovascular disease (such as chf), clinically significant hepatic, respiratory or renal abnormalities;
boolean
C0007222 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C4018871 (UMLS CUI [4])
C0151746 (UMLS CUI [5])
Laboratory test result abnormal
Item
patient who has any clinically significant abnormalities in laboratory results at screening
boolean
C0438215 (UMLS CUI [1])
Nervous system disorder | Mental condition Clinical Significance
Item
patient who has a history of clinically significant neurological or psychiatric condition;
boolean
C0027765 (UMLS CUI [1])
C3840291 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
Criteria Additional | Cohort Expanded
Item
additional criteria are applicable to expansion cohorts.
boolean
C0243161 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C0599755 (UMLS CUI [2,1])
C0205229 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial